MEDS Apotek (MEDS) ABGSC Investor Days summary
Event summary combining transcript, slides, and related documents.
ABGSC Investor Days summary
5 Dec, 2025Leadership and management
Executive team includes experienced professionals with backgrounds in strategic management, finance, and e-commerce, including prior roles at Boingo, Babyshop, and EY.
Board of Directors features industry veterans from companies such as Goldman Sachs, Postnord, and Apoteket.
Founders and management possess strong expertise in technology and pharmaceuticals.
Market position and growth
Achieved rapid growth, doubling online pharmacy market share in Sweden from 2020 to 2024.
Net sales reached SEK 972m with a 39% CAGR from 2020 to 2024.
Exceeded 1 million active customers and SEK 1 billion in annualized net sales.
Swedish market is a European leader in online prescription medicine sales, with high online penetration.
Business model and technology
Operates a proprietary technology platform with 100% in-house development, enabling cost efficiency and flexibility.
Logistics are semi-automated and scalable, with further expansion planned for 2026.
E-commerce model offers significant environmental benefits and superior customer convenience compared to physical stores.
Latest events from MEDS Apotek
- Record SEK 1 billion sales, strong Rx growth, and expanded logistics drive future growth.MEDS
Q4 202512 Feb 2026 - Q3 sales up 22%, RX up 52%, IPO raised 70 MSEK, and profitability improved.MEDS
Q3 202510 Feb 2026 - Revenue up 27% to SEK 837.4m, losses narrowed, and Q4 turned positive.MEDS
Q4 202423 Oct 2025